Literature DB >> 20035034

Does TREAT give the boot to ESAs in the treatment of CKD anemia?

Ajay K Singh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035034     DOI: 10.1681/ASN.2009111127

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  20 in total

1.  Anemia: What can we learn from a secondary analysis of CHOIR?

Authors:  Walter H Hörl
Journal:  Nat Rev Nephrol       Date:  2010-05       Impact factor: 28.314

Review 2.  Drug therapy in patients with chronic renal failure.

Authors:  Bertram Hartmann; David Czock; Frieder Keller
Journal:  Dtsch Arztebl Int       Date:  2010-09-17       Impact factor: 5.594

3.  Efficiency of U.S. dialysis centers: an updated examination of facility characteristics that influence production of dialysis treatments.

Authors:  Sanatan Shreay; Martin Ma; Jill McCluskey; Ron C Mittelhammer; Matthew Gitlin; J Mark Stephens
Journal:  Health Serv Res       Date:  2013-11-18       Impact factor: 3.402

Review 4.  Anaemia management and mortality risk in chronic kidney disease.

Authors:  Walter H Hörl
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

Review 5.  Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis.

Authors:  Emilee R Wilhelm-Leen; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2015-01-28       Impact factor: 8.860

6.  Anaemia: Does the KDIGO guideline move the needle in CKD anaemia?

Authors:  Ajay K Singh
Journal:  Nat Rev Nephrol       Date:  2012-09-25       Impact factor: 28.314

7.  Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents.

Authors:  Terumasa Hayashi; Tomonori Kimura; Keiko Yasuda; Yoshitsugu Obi; Koichi Sasaki; Kenichiro Iio; Kenro Miyasato; Taro Kamimura; Harumi Kitamura; Yoshiharu Tsubakihara; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2012-10-26       Impact factor: 2.801

Review 8.  Intravenous iron in heart failure: beyond targeting anemia.

Authors:  Donald S Silverberg; Adrian Iaina; Doron Schwartz; Dov Wexler
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 9.  Diabetes, anemia and CKD: Why TREAT?

Authors:  Ajay K Singh
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

10.  Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.

Authors:  Wolfgang C Winkelmayer; Tara I Chang; Aya A Mitani; Emilee R Wilhelm-Leen; Victoria Ding; Glenn M Chertow; M Alan Brookhart; Benjamin A Goldstein
Journal:  Am J Kidney Dis       Date:  2015-05-02       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.